Atara Biotherapeutics, Inc. (ATRA)
NASDAQ: ATRA · Real-Time Price · USD
4.830
-0.170 (-3.40%)
Mar 6, 2026, 11:22 AM EST - Market open
Atara Biotherapeutics Market Cap
Atara Biotherapeutics has a market cap or net worth of $34.83 million as of March 6, 2026. Its market cap has decreased by -22.26% in one year.
Market Cap
34.83M
Enterprise Value
39.30M
1-Year Change
-22.26%
Ranking
Category
Stock Price
$4.83
Market Cap Chart
Since October 16, 2014, Atara Biotherapeutics's market cap has decreased from $215.30M to $34.83M, a decrease of -83.82%. That is a compound annual growth rate of -14.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 36.10M | -72.32% |
| Dec 31, 2025 | 130.40M | 70.01% |
| Dec 31, 2024 | 76.70M | 46.65% |
| Dec 29, 2023 | 52.30M | -83.19% |
| Dec 30, 2022 | 311.20M | -77.67% |
| Dec 31, 2021 | 1.39B | -8.65% |
| Dec 31, 2020 | 1.53B | 71.04% |
| Dec 31, 2019 | 891.90M | -43.76% |
| Dec 31, 2018 | 1.59B | 186.35% |
| Dec 29, 2017 | 553.80M | 35.14% |
| Dec 30, 2016 | 409.80M | -45.80% |
| Dec 31, 2015 | 756.10M | 39.84% |
| Dec 31, 2014 | 540.70M | 151.14% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veru Inc. | 40.29M |
| Palatin Technologies | 40.10M |
| Xilio Therapeutics | 40.00M |
| Sensei Biotherapeutics | 39.77M |
| Jasper Therapeutics | 39.74M |
| Actinium Pharmaceuticals | 38.37M |
| PDS Biotechnology | 38.30M |
| NovaBay Pharmaceuticals | 38.14M |